Diaran Mr 30 30 mg. MR tablets
PDF Leaflet Revision Date: 30 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Type II diabetes mellitus.
Dosage (summary)
Initial dose 30 mg once daily with breakfast; may increase to 120 mg based on response.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Miconazole
- Alcohol
- Fluoroquinolones
Contraindications
- Hypersensitivity to gliclazide
- Type 1 diabetes
- Severe renal or hepatic insufficiency
Common side effects
- Hypoglycaemia
- Abdominal pain
- Nausea
- Skin reactions
Counselling Points
- Take with breakfast
- Monitor blood glucose regularly
- Be aware of hypoglycaemia symptoms
Serious warnings
- Risk of hypoglycaemia
- Increased cardiovascular mortality
- Careful monitoring in renal impairment
Important Disclaimer
The Diaran Mr 30 30 mg. MR tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
